The initial management of stable angina in Europe, from the Euro Heart Survey
Open Access
- 16 February 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 26 (10), 1011-1022
- https://doi.org/10.1093/eurheartj/ehi109
Abstract
Aims In order to assess adherence to guidelines and international variability in management, the Euro Heart Survey of Newly Presenting Angina prospectively studied medical therapy, percutaneous coronary intervention (PCI), and surgery in patients with new-onset stable angina in Europe. Methods and results Consecutive patients, 3779 in total, with a clinical diagnosis of stable angina by a cardiologist were enrolled. After initial assessment by a cardiologist, 78% were treated with aspirin, 48% with a statin, and 67% with a beta-blocker. ACE-inhibitors were prescribed by the cardiologist in 37% overall. Revascularization rates were low, with only 501 (13%) patients having PCI or coronary bypass surgery performed or planned. However, when restricted to patients with coronary disease documented within 4 weeks of assessment, over 50% had revascularization performed or planned. Among other factors, the national rate of angiography and availability of invasive facilities significantly predicted the likelihood of revascularization, OR 2.4 and 2.0, respectively. Conclusion This survey shows a shortfall between guidelines and practice with regard to the use of evidence-based drug therapy and evidence that revascularization rates are strongly influenced by non-clinical, in addition to clinical, factors.Keywords
This publication has 29 references indexed in Scilit:
- The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable AnginaEuropean Heart Journal, 2005
- Silent Myocardial IschemiaCirculation, 2003
- Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)The Lancet, 2003
- ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina—Summary ArticleCirculation, 2003
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Management of stable angina pectoris: Recommendations of the Task Force of the European Society of CardiologyEuropean Heart Journal, 1997
- Prognosis of patients with stable angina pectoris on antianginal drug therapyThe American Journal of Cardiology, 1996
- Total Ischaemic Burden European Trial (TIBET): Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable anginaEuropean Heart Journal, 1996
- Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists CollaborationThe Lancet, 1994
- Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study.Circulation, 1990